Last $61.38 USD
Change Today -0.58 / -0.94%
Volume 1.1M
PRXL On Other Exchanges
As of 8:10 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mark A. Goldberg M.D.

President and Chief Operating Officer, PAREXEL International Corporation
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

As of Fiscal Year 2013


Dr. Mark A. Goldberg, M.D., has been the President and Chief Operating Officer of PAREXEL International Corporation since July 1, 2012 and July 2008 respectively. Dr. Goldberg served as Chief Operating Officer of Parexel Informatics, Inc. He served in management capacities of increasing responsibility at Genzyme from 1996 to 2011, including as Senior Vice President for Clinical Development and Global Therapeutic Group Head for Oncology and Personalized Genetic Health. ...

Read Full Background

Corporate Headquarters*

195 West Street
Waltham, Massachusetts 02451

United States

Phone: 781-487-9900
Fax: 781-487-0525

Board Members Memberships*

There is no Board Members Memberships data available.


Bachelor's Degree
Massachusetts Institute of Technology
The University of Massachusetts Medical School

Other Affiliations*

Annual Compensation*

Total Annual Compensation$541,667

Stock Options*

Restricted Stock Awards$500,410
All Other Compensation$15,332
Exercised Options62,000
Exercised Options Value$1,287,747
Exercisable Options60,900
Exercisable Options Value$1,069,739
Unexercisable Options96,900
Unexercisable Options Value$2,247,999
Total Value of Options$4,605,485
Total Number of Options219,800

Total Compensation*

Total Annual Cash Compensation$943,063
Total Short Term Compensation$541,667
Other Long Term Compensation$515,742
Total Calculated Compensation$1,911,528
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PRXL:US $61.38 USD -0.58


James C. Foster J.D.Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Strategic Planning & Capital Allocation Committee
Charles River Laboratories International, Inc.
Joseph L. Herring Chairman and Chief Executive Officer
Covance Inc.
Ciaran Murray Chief Executive Officer, Director and Chairman of Executive Committee
ICON Public Limited Company
Matthias Hartmann Chief Executive Officer and Member of Management Board
Ge Li Ph.D.Co-Founder, Chairman, Chief Executive Officer and Member of Strategy & Finance Committee
WuXi PharmaTech (Cayman) Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PAREXEL INTERNATIONAL CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at